Author:
Guardiola E.,Peyrade F.,Chaigneau L.,Cupissol D.,Tchiknavorian X.,Bompas E.,Madroszyk A.,Ronchin P.,Schneider M.,Bleuze J.P.,Blay J.Y.,Pivot X.
Reference14 articles.
1. Head and neck cancer;Vokes;N. Engl. J. Med.,1993
2. An analysis of overall survival clinical prognostic factors for patients with locally recurrent or metastatic head and neck squamous cell carcinoma;Pivot;Proc. Am. Soc. Clin. Oncol.,2000
3. A phase III randomised trial of cisplatinum, methotrextate, cisplatinum + methotrexate and cisplatinum+5-FU in end stage squamous carcinoma of the head and neck. Liverpool Head and Neck Oncology Group. Br J Cancer 1990, 61, 311–315.
4. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a southwest oncology group study;Forastiere;J. Clin. Oncol.,1992
5. A randomised prospective comparison of methotrexate with a combination of methotrexate, bleomycin, and cisplatin in head and neck cancer;Vogl;Cancer,1985
Cited by
102 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献